2022年ADA糖尿病诊治指南StandardsofMedicalCareinDiabetes—2022AMERICANDIABETESASSOCIATIONCONTENTSI.CLASSIFICATIONANDDIAGNOSISOFDIABETES,p.S12A.Classi?cationofdiabetesB.DiagnosisofdiabetesC.Categoriesofincreasedriskfordi-abetes(prediabetes)II.TESTINGFORDIABETESINASYMP-TOMATICPATIENTS,p.S13A.Testingfortype2diabetesandriskoffuturediabetesinadultsB.Testingfortype2diabetesinchil-drenC.Screeningfortyp...
ADA糖尿病指南-2022StandardsofMedicalCareinDiabetes—2022AMERICANDIABETESASSOCIATIONDiabetesisachronicillnessthatre-quirescontinuingmedicalcareandongoingpatientself-managementeducationandsupporttopreventacutecomplicationsandtoreducetheriskoflong-termcomplications.Diabetescareiscomplexandrequiresthatmanyissues,beyondglycemiccontrol,beaddressed.Alargebodyofevidenceexiststhatsup-portsar...
腺苷脱氨酶（ADA）在胸腔积液中的应用分析【中图分类号】R655【文献标识码】A【文章编号】1672-5085（2012）7-0185-02【摘要】目的探讨腺苷脱氨酶(ADA)在胸腔积液鉴别诊断的临床价值。方法回顾分析128例产生胸腔积液患者的病历资料，依据临床诊断分为88例结核性胸腔积液和40例恶性胸腔积液病例，分析胸腔积液腺苷脱氨酶活性，及血清腺苷脱氨酶活性，两组数据进行对比分析。结果88例结核性胸腔积液腺苷脱氨酶活性65.7±12.4U/L较...
